Some of the material in is restricted to members of the community. By logging in, you may be able to gain additional access to certain collections or items. If you have questions about access or logging in, please use the form on the Contact Page.
Love, K., Miller, M., Pemberton, K., & Rodríguez, J. (2013). What Are the Risks of Oral Contraceptives in Patients with Cardiovascular Disease Risk
Factors? Evidence Based Practice. Retrieved from http://purl.flvc.org/fsu/fd/FSU_migr_fmr-0047
Women who smoke, have hypertension, hyperlipidemia, or factor V Leiden deficiency and take oral contraception (OC) are at increased risk of myocardial infarction (MI). Third-generation OCs and low-dose OCs are not associated with increased MI risk in women with or without other cardiovascular (CV) risk factors (SOR B, systematic review of cohort studies). OCs are contraindicated in women with preexisting congestive heart failure or CV disease, but may be used in otherwise healthy women with diabetes, hypertension, or hyperlipidemia (SOR C, evidence-based guidelines derived from consensus and expert opinion).
Love, K., Miller, M., Pemberton, K., & Rodríguez, J. (2013). What Are the Risks of Oral Contraceptives in Patients with Cardiovascular Disease Risk
Factors? Evidence Based Practice. Retrieved from http://purl.flvc.org/fsu/fd/FSU_migr_fmr-0047
